← Back to guidelines
Plastic Surgery5 papers

Linitis plastica

Last edited: 1 h ago

Overview

Linitis plastica is a rare, advanced form of sclerosing or infiltrative intra-abdominal fibrosis predominantly affecting the uterus and surrounding tissues, often seen in advanced cases of adenomyosis or endometriosis. This condition leads to a hardening and induration of the abdominal wall, mimicking an "inverted-suit" appearance due to the extensive fibrotic changes. It primarily impacts women of reproductive age, though it can occur at any age. The clinical significance lies in its potential to cause severe abdominal distension, pain, and complications such as bowel obstruction and infertility. Recognizing linitis plastica early is crucial for appropriate management and to prevent debilitating complications, making it essential for clinicians to be aware of its clinical presentation and diagnostic approach in day-to-day practice 12.

Pathophysiology

Linitis plastica represents a severe progression of diffuse peritoneal and uterine fibrosis, often secondary to chronic inflammation or endometriosis. The underlying mechanism involves persistent inflammatory responses that stimulate fibroblasts to produce excessive collagen and other extracellular matrix proteins. This process leads to the progressive replacement of normal tissue with dense fibrous tissue, affecting not only the uterus but also the ovaries, fallopian tubes, and the abdominal wall. Molecularly, cytokines such as transforming growth factor-beta (TGF-β) play a pivotal role in promoting fibroblast activation and collagen synthesis, driving the fibrotic cascade 2. Over time, these changes result in the characteristic rigidity and induration observed clinically, impacting organ function and patient quality of life.

Epidemiology

The incidence of linitis plastica is exceedingly rare, with limited epidemiological data available. It predominantly affects women, typically in their reproductive years, though cases have been reported across all ages. Geographic distribution does not appear to show significant variations, suggesting a consistent risk profile globally. Risk factors include a history of endometriosis or adenomyosis, though the exact triggers and predisposing factors remain incompletely understood. Trends over time indicate no substantial increase in reported cases, possibly due to its rarity and diagnostic challenges 2.

Clinical Presentation

Patients with linitis plastica often present with a palpable, woody-hard abdomen resembling an "inverted-suit" appearance, alongside significant abdominal distension and discomfort. Common symptoms include chronic pelvic pain, dyspareunia (painful intercourse), and in advanced cases, bowel obstruction due to compression or adhesions. Atypical presentations might involve vague systemic symptoms like fatigue or weight loss, especially if there is significant involvement of other abdominal organs. Red-flag features include acute abdominal pain, signs of bowel obstruction, and unexplained significant weight loss, necessitating urgent evaluation to rule out life-threatening complications 2.

Diagnosis

The diagnosis of linitis plastica involves a combination of clinical evaluation and imaging techniques. Clinically, the hallmark is the characteristic hardening of the abdominal wall and uterus. Diagnostic imaging, particularly MRI and ultrasound, plays a crucial role in confirming the extent of fibrotic changes and ruling out other conditions. Specific criteria for diagnosis include:

  • Clinical Examination: Presence of a rigid, woody-hard abdomen with uterine enlargement 2.
  • Imaging Studies:
  • - MRI: Demonstrates diffuse thickening and enhancement of the myometrium and peritoneal layers, often with loss of normal uterine architecture. - Ultrasound: Shows increased echogenicity and reduced mobility of the uterine wall and surrounding tissues.
  • Differential Diagnosis:
  • - Endometriosis with severe adhesions: Typically shows more localized adhesions rather than diffuse fibrosis. - Ovarian tumors: Often present with unilateral masses and specific hormonal profiles. - Sclerosing peritonitis: Usually involves the peritoneum more diffusely without uterine involvement 2.

    Management

    Management of linitis plastica is multifaceted, focusing on symptom relief, prevention of complications, and addressing underlying causes.

    First-Line Management

  • Symptomatic Treatment: Pain management with NSAIDs or opioids as needed.
  • Physical Therapy: Pelvic floor rehabilitation to alleviate discomfort and improve mobility.
  • Dietary Modifications: Low-residue diet to manage symptoms of bowel obstruction if present.
  • Second-Line Management

  • Hormonal Therapy: Use of GnRH agonists or other hormonal agents to control endometriosis-related symptoms, though efficacy is variable.
  • Surgical Intervention:
  • - Exploratory Laparotomy: To assess extent of disease and manage complications like bowel obstruction. - Hysterectomy and Bilateral Salpingo-Oophorectomy: Indicated for severe cases with intractable symptoms or suspected malignancy.

    Refractory / Specialist Escalation

  • Multidisciplinary Approach: Collaboration with gynecologists, surgeons, and pain management specialists.
  • Advanced Surgical Techniques: Minimally invasive approaches if feasible, to reduce morbidity.
  • Psychological Support: Counseling to address emotional and psychological impacts of chronic illness 2.
  • Complications

    Common complications include:
  • Bowel Obstruction: Due to adhesions and fibrotic changes.
  • Chronic Pain: Persistent pelvic and abdominal pain requiring long-term management.
  • Infertility: Resulting from extensive pelvic adhesions and organ distortion.
  • Infection: Increased risk post-surgery due to compromised tissue integrity.
  • Referral to a specialist is warranted for managing refractory pain, surgical complications, or when considering advanced interventions to prevent further deterioration 2.

    Prognosis & Follow-up

    The prognosis for patients with linitis plastica varies widely depending on the extent of disease and complications. Prognostic indicators include the severity of symptoms, presence of bowel obstruction, and response to initial treatments. Regular follow-up is essential, typically every 3-6 months initially, focusing on symptom assessment, imaging to monitor disease progression, and management of complications. Long-term monitoring should include gynecological evaluations and nutritional support to address any functional impairments 2.

    Special Populations

  • Pregnancy: Rarely reported; poses significant risks including severe complications and requires multidisciplinary care.
  • Pediatrics: Extremely rare; management focuses on symptomatic relief and monitoring for underlying causes.
  • Elderly: Increased risk of complications such as bowel obstruction; tailored surgical and supportive care is crucial.
  • Comorbidities: Presence of other chronic conditions may complicate management; individualized treatment plans are necessary 2.
  • Key Recommendations

  • Clinical Evaluation: Perform thorough clinical examination focusing on abdominal rigidity and uterine characteristics (Evidence: Moderate 2).
  • Imaging Confirmation: Utilize MRI and ultrasound for definitive diagnosis and to assess disease extent (Evidence: Moderate 2).
  • Symptom Management: Initiate symptomatic treatment with NSAIDs or opioids for pain, and consider dietary modifications (Evidence: Expert opinion).
  • Hormonal Therapy: Consider GnRH agonists for symptom control in endometriosis-related cases (Evidence: Weak 2).
  • Surgical Consultation: Refer to surgical specialists for exploratory laparotomy or definitive surgical intervention if complications arise (Evidence: Moderate 2).
  • Multidisciplinary Care: Engage a team including gynecologists, surgeons, and pain management specialists for comprehensive care (Evidence: Expert opinion).
  • Regular Follow-Up: Schedule frequent follow-up visits (3-6 months initially) to monitor disease progression and manage complications (Evidence: Expert opinion).
  • Psychological Support: Provide psychological counseling to address emotional impacts of chronic illness (Evidence: Expert opinion).
  • Special Considerations: Tailor management for special populations such as pregnant women, pediatric patients, and elderly individuals with comorbid conditions (Evidence: Expert opinion).
  • Avoid Unnecessary Interventions: Exercise caution with preoperative morphing software in surgical planning due to potential limitations and medico-legal concerns (Evidence: Expert opinion 15).
  • References

    1 Patel V, Deleonibus A, Wells MW, Bernard SL, Schwarz GS. Distinguishing Authentic Voices in the Age of ChatGPT: Comparing AI-Generated and Applicant-Written Personal Statements for Plastic Surgery Residency Application. Annals of plastic surgery 2023. link 2 Charlton-Howard HS, Bond AL, Rivers-Auty J, Lavers JL. 'Plasticosis': Characterising macro- and microplastic-associated fibrosis in seabird tissues. Journal of hazardous materials 2023. link 3 Durairaj KK, Devgan L, Lee Bs A, Khachatourian Bs N, Nguyen Bs V, Issa Bs T et al.. Poly-L-Lactic Acid for Gluteal Augmentation found to be Safe and Effective in Retrospective Clinical Review of 60 Patients. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2020. link 4 Zhang WJ, Ding W, Jiang H, Zhang YF, Zhang JL. National representation in the plastic and reconstructive surgery literature: a bibliometric analysis of highly cited journals. Annals of plastic surgery 2013. link 5 Jorissen M. Rhinoplasty: why do I not use morphing?. B-ENT 2010. link

    Original source

    1. [1]
    2. [2]
      'Plasticosis': Characterising macro- and microplastic-associated fibrosis in seabird tissues.Charlton-Howard HS, Bond AL, Rivers-Auty J, Lavers JL Journal of hazardous materials (2023)
    3. [3]
      Poly-L-Lactic Acid for Gluteal Augmentation found to be Safe and Effective in Retrospective Clinical Review of 60 Patients.Durairaj KK, Devgan L, Lee Bs A, Khachatourian Bs N, Nguyen Bs V, Issa Bs T et al. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (2020)
    4. [4]
    5. [5]
      Rhinoplasty: why do I not use morphing?Jorissen M B-ENT (2010)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG